KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to 0.14%.

  • Amneal Pharmaceuticals' Return on Capital Employed rose 600.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.11% for FY2024, which is 300.0% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.14% for Q3 2025, which was up 600.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Capital Employed registered a high of 0.16% during Q2 2025, and its lowest value of 0.05% during Q2 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' median Return on Capital Employed value was 0.06% (recorded in 2024), while the average stood at 0.06%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -900bps in 2022, then soared by 1200bps in 2023.
  • Amneal Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.05% in 2021, then crashed by -166bps to 0.03% in 2022, then surged by 343bps to 0.07% in 2023, then skyrocketed by 42bps to 0.11% in 2024, then grew by 27bps to 0.14% in 2025.
  • Its Return on Capital Employed was 0.14% in Q3 2025, compared to 0.16% in Q2 2025 and 0.15% in Q1 2025.